PER
Click for more information
4.29% 6.7¢ percheron therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-14

  1. dalts66
    4,336 Posts.
    lightbulb Created with Sketch. 2023
    clock Created with Sketch.
    25/01/23
    10:47
    Post #: 65870947
    One of the better reports seen from ANP. I am liking this investigation into cd49 ailments. Multiple kicks at goal from the one drug

    Still risk, but incredible value at this market cap.
    Likes Created with Sketch. 12  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

CPV ClearVue shares up 15% as it inks deal to enter Middle East and Indian construction markets
right-arrow Created with Sketch.
GRX GreenX picks up prospective copper project in Germany
right-arrow Created with Sketch.
NEWS A Super PITch is key in the competition for capital
right-arrow Created with Sketch.
MND Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
right-arrow Created with Sketch.
STX Strike reports flow test success at 100% owned Walyering-7
right-arrow Created with Sketch.
VMT Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
6.7¢ 		Change
-0.003(4.29%) 		Mkt cap ! $60.40M
Open High Low Value Volume
7.0¢ 7.0¢ 6.7¢ $43.41K 636.5K

Buyers (Bids)

No. Vol. Price($)
1 32916 6.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 35754 1
View Market Depth
Last trade - 16.10pm 05/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.